1000/1000
Hot
Most Recent
Bidirectional communication between cells and their microenvironment has a key function in normal tissue homeostasis and for disease initiation, progression and patient’s prognosis at least. The extracellular matrix (ECM), as an element of all tissues and cellular microenvironment, is a frequently overlooked component in implication in pathogenesis and progression of several diseases. In inflammatory microenvironment (IME) different alterations affect ECM resulting from remodeling processes which progressively induce cancer initiation and the passage toward a tumor microenvironment (TME). Indeed, it is demonstrated that altered ECM components interact with a variety of surface receptors triggering intracellular signaling that, in turn, affect cellular pathways. Supporting this concept, new studies have offered exciting clues about the function of decellularized ECM (dECM) and its components, as active participants in cancer and inflammation diseases evolution, once matched it with other cellular elements. Research results support the notion that the ECM, rather than acting as a passive element, is an active participant in promotion of chronic inflammatory and cancer initiation. Particularly it highlights the different effects of ECM components alterations in both disease and the correlation between chronic inflammation and cancer initiation. In conclusion, it soughts to explore the employment of dECM models as a tool to prevent cancer initiation. Indeed, reporting some of the data obtained in cancer research, it reflects about the employment of dECM models to investigate the short-circuits contributing to create distinct IME, representing, thus, a potential tool to avoid the progression toward a malignant lesion.
Cells can sense all mechanical and biochemical properties of ECM through cell surface and transmembrane receptors. These receptors bind cells to the ECM components and transmit mechanical and chemical signals from ECMs to cells. Integrins are typical matrix receptors which mediate ECM and cell communication. Their function is to connect their extracellular domain with matrix molecules and interact with actin cytoskeleton, through their cytoplasmic tails, thus regulating cell adhesion and motility [7][8][9]. Integrins can be activated through two different mechanisms, either inside-out or outside-in signaling [6]. Indeed, biochemical signals coming from intracellular space can induce conformational changes in the integrin extracellular domain. These changes facilitate ECM ligand binding through the promotion of talin and kindlin recruitment to the cytoplasmatic tails. Regarding the outside-in signaling in ECM, ligands bind to the extracellular domain of integrin and contribute to the recruitment of talin and kindlin to their cytoplasmatic tail. Talin molecules connect the actin cytoskeleton to the integrin and the activation signaling induces conformational alterations that lead to the intracellular recruitment of scaffolding proteins, such as focal adhesion kinase (FAK), which promote cell signaling. The integrin-ECM ligand linkage stimulates FAK/SRC complex assembly at the tails of integrins, recruiting various downstream effectors which activate Pl3K/Akt and Ras/MEK/ERK pro-survival signaling [10].
For biomechanical properties, cells can sample them and tune intracellular signaling pathways through a process termed mechano-transduction [11]. As it turns out, the elasticity of ECM (which can range from soft and compliant to stiff and rigid) helps to coordinate how a cell senses and perceives external forces and stimuli [12][13], providing major environmental cues that affect cell behavior [14][15]. Cells use actomyosin contractibility to remodel the ECM and to sense its material properties or stiffness while integrins, DDr receptors and FAKs mediate cells response [6].
The ECM components are normally cleaved and degraded by pericellular target-specific remodeling and degrading enzymes. Among them, various proteases such as soluble and membrane-bound metalloproteinases (MMPs), disintegrin and metalloproteinases (ADAMs), disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS), cathepsins, bone morphogenic protein1 and Tolloid-like proteinases, as well as hyaluronindase and heparanase, are mainly involved. MMPs are of outstanding importance in ECM remodeling, and are crucially involved in cancer progression more than the other ECM-degrading enzymes [18]. The MMP family comprises 28 members and, depending on their type, these can have gelatinolytic and collagenolytic activity toward the ECM. MMPs’ proteolytic activity is triggered by an activation cascade through which it is secreted as zymogens (pro-MMPs) without biological activity and kept inactive until the disruption of the interaction between the conserved cysteine in the propetide domain and the zinc ion bound to the catalytic domain. The activation cascade can include endogenous inhibitors, such as the case of MMP-2 which requires a tissue inhibitor of metalloproteinases (TIMP)-2 to be activated by MMP-13. TIMPs are a protein family which, forming a complex with their own N-terminal domain and chelating the catalytic zinc ion in the active center of MMP, function as natural MMPs inhibitors. Nevertheless, TIMPs can also interact with their C-terminal domain with the hemopexin domain of MMPs and thereby activate them [19].